Exponent
EXPO
203 hedge funds and large institutions have $1.63B invested in Exponent in 2017 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 81 increasing their positions, 60 reducing their positions, and 13 closing their positions.
154% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 13
35% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 60
11% more funds holding
Funds holding: 183 → 203 (+20)
5% less capital invested
Capital invested by funds: $1.71B → $1.63B (-$79.8M)
1.82% less ownership
Funds ownership: 179.12% → 177.29% (-1.8%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$17.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.4M |
| 3 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$8.69M |
| 4 |
Millennium Management
New York
|
+$7.1M |
| 5 |
LCM
Laurion Capital Management
New York
|
+$6.11M |
Top Sellers
EXPO Hedge Fund Activity: Q4 2017 in Review
203 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Exponent (EXPO) for Q4 2017, worth a combined $1.63B — down 4.7% from $1.71B a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new EXPO positions and 13 closed out — a net gain of 20 holders — while 81 added to existing stakes and 60 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $17.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $55M.
- 203 institutional investors held Exponent (EXPO) as of Q4 2017, up from 183 in Q3 2017.
- Funds reported $1.63B of Exponent stock for Q4 2017, down 4.7% quarter-over-quarter.
- 33 funds opened new Exponent positions in Q4 2017 and 13 closed out, a net change of +20 holders.
- The largest Exponent buyer in Q4 2017 was Janus Henderson Group, an estimated $17.5M added.
- The largest Exponent seller in Q4 2017 was T. Rowe Price Associates, an estimated $55M sold.
Based on aggregated 13F filings for Q4 2017.